Abstract: A method of sensitizing a patient's immune system is disclosed. The method includes forming a reagent comprising an ultraviolet light-sensitive chemical, and optionally an antibody. The method preferably includes wherein the antibody is specific for a target cell of a patient, a target host cell of a patient or a blood-borne microbial pathogen. A composition is provided comprising an antibody and an ultraviolet light-sensitive chemical wherein the ultraviolet light-sensitive chemical is preferably a psoralen or psoralen-derived light-sensitive chemical.

Abstract: The present invention provides pharmacologically active compositions of drugs of addiction, or their respective agonists or antagonists in a variety of unit-dose or multidose drug delivery systems, including those for transdermal, intranasal and sublingual administration, and methods of use thereof. A patient individualized addiction cessation therapy treatment method is also provided that step-wise decreases the addictive substance from the patient's central nervous system over time. A computerized data processing system and method for assisting medical practitioners in selecting a medical treatment for a patient based upon known medical and clinical data and outcomes are disclosed.